Steward Partners Investment Advisory’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$263K Buy
2025
Q2
$257K Hold
2025
Q1
$269K Buy
2024
Q4
$98.5K Buy
2024
Q3
$30.2K Buy
2024
Q2
$11.9K Buy
2024
Q1
$5.81K Buy
2023
Q4
$4.93K Buy